BioArctic Logo

BioArctic

ISIN: SE0010323311 | Ticker: BIOA | LEI: 549300Y0OI2WVUNHLC33
Sector: Health CareSub-Industry: Biotechnology
Country: Sweden

About BioArctic

Company Description

BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of disorders that affect the Central Nervous System. These types of treatments are commonly referred to as “disease modifiers”. They affect the underlying disease pathology and can hopefully stop or significantly delay disease progression. This is a large paradigm shift from today’s symptom-oriented therapies.

BioArctic’s proprietary technology platform, dedicated personnel, collaborations with leading academic research groups and the global pharma industry have made it possible to develop innovative treatments based on antibodies (immunotherapy) for neurodegenerative disorders.

Our main research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. Today there are no treatments that can stop or slow down the progression of these diseases.

Year founded

1992

Headquarters

Warfvinges väg 35, 11251 Stockholm – Sweden

Financial statements

Download as Excel
Line item in (sek) 02.01.2020 01.01.2021 02.01.2021 01.01.2022 02.01.2022 01.01.2023
Assets N/A 1,050,313,000.00 N/A 897,730,000.00 N/A 858,307,000.00
Noncurrent Assets N/A 41,953,000.00 N/A 35,944,000.00 N/A 37,466,000.00
Property Plant And Equipment N/A 18,120,000.00 N/A 16,963,000.00 N/A 23,531,000.00
Deferred Tax Assets N/A 452,000.00 N/A 608,000.00 N/A 596,000.00
Other Noncurrent Financial Assets N/A 1,562,000.00 N/A 1,588,000.00 N/A 1,606,000.00
Current Assets N/A N/A N/A 861,786,000.00 N/A 820,841,000.00
Trade And Other Current Receivables N/A 0.00 N/A 2,839,000.00 N/A 0.00
Other Current Receivables N/A 4,255,000.00 N/A 4,648,000.00 N/A 6,740,000.00
Cash and cash equivalents 999,940,000.00 999,940,000.00 848,405,000.00 848,405,000.00 N/A 805,386,000.00
Equity And Liabilities N/A 1,050,313,000.00 N/A 897,730,000.00 N/A 858,307,000.00
Equity 974,497,000.00 907,299,000.00 907,299,000.00 788,676,000.00 788,676,000.00 786,241,000.00
Issued Capital N/A 1,761,000.00 N/A 1,761,000.00 N/A 1,763,000.00
Retained Earnings N/A 344,562,000.00 N/A 225,939,000.00 N/A 217,520,000.00
Share Premium N/A 560,018,000.00 N/A 560,018,000.00 N/A 566,001,000.00
Other Reserves N/A 958,000.00 N/A 958,000.00 N/A 958,000.00
Equity Attributable To Owners Of Parent N/A 907,299,000.00 N/A 788,676,000.00 N/A 786,241,000.00
Noncurrent Liabilities N/A 34,293,000.00 N/A 7,785,000.00 N/A 1,182,000.00
Deferred Tax Liabilities N/A 20,666,000.00 N/A 0.00 N/A N/A
Current Liabilities N/A 108,721,000.00 N/A 101,268,000.00 N/A 70,883,000.00
Trade And Other Current Payables N/A 14,311,000.00 N/A 11,818,000.00 N/A 21,491,000.00
Current Tax Liabilities Current N/A 0.00 N/A 0.00 N/A 0.00
Other Current Liabilities N/A 3,576,000.00 N/A 3,919,000.00 N/A 5,427,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 62,347,000.00 23,146,000.00 228,291,000.00
Employee Benefits Expense 62,977,000.00 72,499,000.00 115,650,000.00
Depreciation And Amortisation Expense 11,013,000.00 13,107,000.00 14,633,000.00
Other Expense By Nature 23,370,000.00 24,852,000.00 33,015,000.00
Finance Income 7,000.00 194,000.00 7,025,000.00
Finance Costs 1,686,000.00 984,000.00 751,000.00
Profit Loss Before Tax -86,691,000.00 -140,512,000.00 -11,168,000.00
Income Tax Expense Continuing Operations -18,174,000.00 -20,723,000.00 11,000.00
Profit Loss From Continuing Operations -68,517,000.00 -119,789,000.00 -11,179,000.00
Profit (loss) -85,012,000.00 -139,723,000.00 -17,442,000.00
Profit Loss Attributable To Owners Of Parent -68,517,000.00 -119,789,000.00 -11,179,000.00
Line item in (sek) 01.01.2021 02.01.2020 01.01.2022 02.01.2021 01.01.2023
Profit (loss) -85,012,000.00 N/A -139,723,000.00 N/A -17,442,000.00
Adjustments For Decrease Increase In Other Operating Receivables 23,086,000.00 N/A -5,122,000.00 N/A -2,414,000.00
Adjustments For Increase Decrease In Other Operating Payables 3,472,000.00 N/A 62,000.00 N/A 27,328,000.00
Other Adjustments For Noncash Items -19,991,000.00 N/A 5,230,000.00 N/A -41,234,000.00
Cash Flows From Used In Operations -92,341,000.00 N/A -140,457,000.00 N/A -31,638,000.00
Interest Paid Classified As Operating Activities -1,686,000.00 N/A -984,000.00 N/A -751,000.00
Interest Received Classified As Operating Activities 7,000.00 N/A 388,000.00 N/A 2,535,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities 12,473,000.00 N/A 4,386,000.00 N/A 12,746,000.00
Other Inflows Outflows Of Cash Classified As Investing Activities -51,000.00 N/A -27,000.00 N/A -18,000.00
Cash Flows From Used In Investing Activities -12,524,000.00 N/A -4,412,000.00 N/A -12,763,000.00
Payments Of Lease Liabilities Classified As Financing Activities 6,598,000.00 N/A 7,389,000.00 N/A 8,793,000.00
Dividends Paid Classified As Financing Activities 0.00 N/A 0.00 N/A -5,985,000.00
Cash Flows From Used In Financing Activities -6,598,000.00 N/A -7,389,000.00 N/A -2,808,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes -111,463,000.00 N/A -152,257,000.00 N/A -47,209,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents -1,367,000.00 N/A 723,000.00 N/A 4,190,000.00
Cash and cash equivalents 999,940,000.00 999,940,000.00 848,405,000.00 848,405,000.00 805,386,000.00

Please note that some sums might not add up.

Filings & Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume
18.02.24 Gunilla Margaretha Andersson Other Other SEK 418,000.00
18.02.24 Gunilla Margaretha Andersson Other Sell SEK 0.00
08.11.23 Eugen Steiner Other Buy SEK 212,390.00
06.10.23 Johanna Margareta Fälting Other Sell SEK 2,800,000.00
27.07.23 Cecilia Edström Other Buy SEK 1,013,204.85
02.06.23 Sten Mikael Moge Other Sell SEK 164,400.00
31.05.23 Oskar Bosson Other Sell SEK 785,250.00
30.05.23 Oskar Bosson Other Sell SEK 924,235.00
21.05.23 Johanna Margareta Fälting Other Other SEK 627,000.00
19.05.23 Sten Mikael Moge Other Sell SEK 619,866.00

Capital markets information

ISIN

SE0010323311

LEI

549300Y0OI2WVUNHLC33

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.